Trials Sponsors Conditions Drugs Pricing

Conditions

Gait, Perturbation Gait, Stumbling

Outcome Measures

Primary Outcomes (2)

Calculation of Margins of Stability (MoS) in anterior-posterior direction at foot contact
Difference between base of support and interpolated center of mass (mm), based on 3D motion capture.
Once during visit 1
Step length at baseline, before (Pre) and after (Recovery step 1-10) perturbation
Once during visit 1

Secondary Outcomes (12)

Step width at foot contact of baseline, before (Pre) and Recovery steps 1-10
Once during visit 1
Calculation of Margin of stability medial-lateral direction at foot contact of baseline, before (Pre) and Recovery steps 1-10
Once during visit 1
Maximal trunk velocity during gait cycle at of baseline, before (Pre) and Recovery steps 1-10 to detect fast trunk movement to gain balance
Once during visit 1
3D kinematic gait profiles to analyze detailed movement patterns/strategies
Once during visit 1
EMG analysis to detect reaction time and activity patterns of different leg muscles
Once during visit 1
+7 more secondary outcomes

Study Arms (2)

Healthy participants between 18 and 40 years of age

Other: Mechanical pertubation

Healthy participants between 60 and 80 years of age

Other: Mechanical pertubation

Interventions

Mechanical pertubationOther

Acceleration or deacceleration of one treadmill gait belt.

Healthy participants between 18 and 40 years of ageHealthy participants between 60 and 80 years of age

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 80 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Healthy population

You may qualify if:

Healthy subjects aged 18-40 years and 60-80 years

Sponsors & Collaborators

University of Zurich
Otherlead

Study Sites (1)

Balgrist Campus

Zurich, Canton of Zurich, 8008, Switzerland

MeSH Terms

Conditions

Gait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

Linard Filli, Dr.
University of Zurich
PRINCIPAL INVESTIGATOR

Enrollment

43 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

March 31, 2023

First Posted

June 6, 2023

Study Start

June 6, 2023

Actual (reported)

Mimicking Slipping Responses Using a Novel Mechanical Perturbation Algorithm

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (12)

Study Arms (2)

Healthy participants between 18 and 40 years of age

Healthy participants between 60 and 80 years of age

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (12)

Study Arms (2)

Healthy participants between 18 and 40 years of age

Healthy participants between 60 and 80 years of age

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations